Bedside Manufacturing of Engineered Stem Cells Using Gene Therapy Foam

Reseachers described a bedside cell manufacturing strategy in which hematopoietic stem cells are genetically targeted within gene therapy foam that is mixed with freshly isolated bone marrow aspirate concentrate and then directly injected back into the marrow.